Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients.
about
Innovative technologies in thoracic radiation therapy for lung cancerToxicity of photodynamic therapy after combined external beam radiotherapy and intraluminal brachytherapy for carcinoma of the upper aerodigestive tract.Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II studyA phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.Dose-escalation study of weekly irinotecan and daily carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer.Phase II trial of S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.Thoracic Vertebral Body Irradiation Contributes to Acute Hematologic Toxicity During Chemoradiation Therapy for Non-Small Cell Lung Cancer.Role of multimodality treatment for lung cancer.Innovative treatment strategies in locally advanced and/or unresectable non-small cell lung cancer.The role of induction therapy in the management of resectable non-small cell lung cancer.Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117.Chemotherapy for non-small cell lung cancer.Risk and predictors for early radiation pneumonitis in patients with stage III non-small cell lung cancer treated with concurrent or sequential chemoradiotherapyLocoregional tumor failure after definitive radiation for patients with stage III non-small cell lung cancer.Large volume unresectable locally advanced non-small cell lung cancer: acute toxicity and initial outcome results with rapid arc.Bevacizumab: the evidence for its clinical potential in the treatment of nonsmall cell lung cancer.Innovative treatments for non-small cell lung cancer.Stereotactic body radiation therapy (SBRT) for lung cancer patients previously treated with conventional radiotherapy: a review.A phase I study of concurrent chemotherapy (paclitaxel and carboplatin) and thoracic radiotherapy with swallowed manganese superoxide dismutase plasmid liposome protection in patients with locally advanced stage III non-small-cell lung cancer.Clinical Responses and Prognostic Indicators of Concurrent Chemoradiation for Non-small Cell Lung Cancer.Platinum drugs in the treatment of non-small-cell lung cancerLung cancer--where are we today? Current advances in staging and nonsurgical treatment.A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321Treatment recommendations for locally advanced, non-small-cell lung cancer: the influence of physician and patient factorsLung cancer. 4: chemotherapy for non-small cell lung cancer: the end of the beginning.A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer.Stereotactic body radiotherapy for re-irradiation of lung cancer recurrence with lower biological effective doses.Image-guided conformal radiation therapy planning and delivery for non-small-cell lung cancer.Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.Combined modality treatment of non-small-cell lung cancer.Defining local-regional control and its importance in locally advanced non-small cell lung carcinomaThe impact of induction chemotherapy and the associated tumor response on subsequent radiation-related changes in lung function and tumor response.Radiation Dose Escalation in Stage III Non-Small-Cell Lung Cancer.Estimating the benefit and cost of radiotherapy for lung cancer.Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancerC-Met inhibitor MK-8003 radiosensitizes c-Met-expressing non-small-cell lung cancer cells with radiation-induced c-Met-expressionDose-finding study of irinotecan and cisplatin plus concurrent radiotherapy for unresectable stage III non-small-cell lung cancer [seecomments].Development of Ad-mda7/IL-24-resistant lung cancer cell lines.Strategies for enhanced radiation delivery in patients with lung cancer.
P2860
Q26863239-03D69112-C02F-4EFE-BA5E-C74385B7F644Q30663661-0DF83BBA-9B2D-4ACA-9A92-6A70E2B5B65AQ33289242-00CAEB12-8AF1-401C-9AC0-B6A7736D0CBAQ33331232-22D64649-DEB8-4AEA-A6A9-70F40B97A5D4Q33343743-A77D4E8C-B2DF-468B-BB37-4860C7EC8BB4Q33385378-BD417D35-FB6E-48A8-9D6F-80474391D304Q33428648-695F7E41-F43F-4706-BD62-260A21699AA6Q33829263-C0DA3CF3-774F-4FF9-B965-F1DDD06BC402Q33877442-58BDDDAB-56E5-4E73-B273-1097439E76C4Q33877447-9301C123-0E33-4C94-8BCC-C3D03C0395D2Q33897625-898648F4-0DB8-4023-BC5C-EC4885EB4226Q33910132-70833C68-9F96-467E-A660-AB209A5C66C1Q33994465-3C047B4B-3F75-4C40-81E1-5BA57F9A9CFCQ34135928-7A6A4147-D7C4-45D0-9B88-C8C2AECB9B37Q34273793-F4B020BD-F5C0-480C-B39F-6A27F9C84FDBQ34450520-ADA20461-5DE6-4CDB-8DDE-0CF7208ED2DBQ34481453-8DBB592B-6587-4AA1-B5C8-77E79F0F6FCCQ34667302-BFEF51F1-5AE7-4C75-A306-302A3EC343C9Q34671664-9A8F30C9-CBC8-46C5-9909-DAEE30AE1655Q34771247-883F068B-054A-452C-B04F-9A319AE13324Q34954760-A05F7281-AE6E-4F5C-AAB9-4E2AF7456294Q34982142-0FEC3865-A341-44E4-9FAE-561D9DDCAFCAQ35058595-FC7ADE3F-8B2C-47DB-A9B5-0F3802E6BD43Q35062350-6D7732C7-58DC-408F-BAF7-DC568A08D66DQ35096015-C7B868BB-1A81-4F77-95E9-2878EDDFEDA2Q35134354-5A0DB4B5-2172-43F7-99DD-DE701C65EF89Q35143867-FB1F5B13-389A-4D3D-B0D5-B4E555C3782EQ35198440-A03BDD00-FAFB-4933-91C7-37EF64F8C3C4Q35268628-F9E001E0-16B7-47C8-BA14-42EBA1C35662Q35532111-934F591A-A0CF-4602-8F74-C6C4AEB0E299Q35627621-E3B01803-8FCE-45CD-8E22-0474D1C27AE8Q35911195-8A7FED55-A3D6-44D3-A97A-B5A9AB5F0DFAQ35946363-FBA686C8-ADB7-422C-ADFA-15294219ED36Q35971034-3598F1DA-41C1-49A1-A9D0-6FBAB632EF32Q35989253-EE3C4216-1D12-48AA-8718-E520A1DF423CQ36080357-ABBD57BA-48F8-4F46-A98D-EA54D9A9C1CAQ36101108-BA251BF1-AE60-4063-BA3C-5D6BCEB62DC9Q36114706-978F2A7E-0B10-4D75-B889-F456CB4747C0Q36235233-215321C9-95C6-496C-969E-059206BF3E2EQ36316678-10C11DC4-C18E-46C0-8840-1B8729E6F8B3
P2860
Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Radiotherapy alone versus comb ...... domized trial in 353 patients.
@en
Radiotherapy alone versus comb ...... domized trial in 353 patients.
@nl
type
label
Radiotherapy alone versus comb ...... domized trial in 353 patients.
@en
Radiotherapy alone versus comb ...... domized trial in 353 patients.
@nl
prefLabel
Radiotherapy alone versus comb ...... domized trial in 353 patients.
@en
Radiotherapy alone versus comb ...... domized trial in 353 patients.
@nl
P2093
P921
P356
P1476
Radiotherapy alone versus comb ...... domized trial in 353 patients.
@en
P2093
Arriagada R
Douillard JY
Lacombe-Terrier MJ
Laplanche A
Le Chevalier T
P304
P356
10.1093/JNCI/83.6.417
P407
P577
1991-03-01T00:00:00Z